• Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
eXoZymes
Home

Technology

The platform Artificial Intelligence BioClick Scientific papers

Pipeline

Pipeline overview NCT: Over-the-Counter NCT: Pharma Cannabinoids Santalene

Investors

Stock information SEC Filings Email signup

About

About eXoZymes Jobs News
  1. Home
  2. interview

Category

interview

12 videos

NCT: Damien on 4 grams of NCT with over 99% purity
investors
NCT: Damien on 4 grams of NCT with over 99% purity July 29, 2025 · 157 views
NCT: From concept to gram-scale quantity in only 5 months
investors
NCT: From concept to gram-scale quantity in only 5 months July 22, 2025 · 181 views
Slack Capital interview: Chris Marlett, Chairman of the Board (teaser)
interview
Slack Capital interview: Chris Marlett, Chairman of the Board (teaser) May 23, 2025 · 44 views
Slack Capital interview: Chris Marlett, Chairman of the Board
interview
Slack Capital interview: Chris Marlett, Chairman of the Board May 23, 2025 · 126 views
Slack Capital interview: Damien Perriman, CCO
investors
Slack Capital interview: Damien Perriman, CCO May 21, 2025 · 101 views
Slack Capital interview: Damien Perriman, CCO (teaser)
investors
Slack Capital interview: Damien Perriman, CCO (teaser) May 21, 2025 · 77 views
Slack Capital interview: Dr. Tyler Korman, VP of Research (teaser)
interview
Slack Capital interview: Dr. Tyler Korman, VP of Research (teaser) May 19, 2025 · 63 views
Slack Capital interview: Tyler Korman, VP of Research
investors
Slack Capital interview: Tyler Korman, VP of Research May 19, 2025 · 73 views
Slack Capital interview: Michael Heltzen, CEO
interview
Slack Capital interview: Michael Heltzen, CEO May 13, 2025 · 137 views
Slack Capital interview: Michael Heltzen, CEO (teaser)
interview
Slack Capital interview: Michael Heltzen, CEO (teaser) May 13, 2025 · 73 views
AI transforming biotechnology: From form with AlphaFold to function with exozymes
investors
AI transforming biotechnology: From form with AlphaFold to function with exozymes April 28, 2025 · 298 views
Bloomberg TV interview with Tyler Korman, co-founder and VP of Research
interview
Bloomberg TV interview with Tyler Korman, co-founder and VP of Research April 15, 2025 · 133 views
  • Previous
  • 1
  • 2
  • 3
  • 4
  • Next

eXoZymes Inc.

750 Royal Oaks Dr, st 106, 
Monrovia 91016, CA, USA

P: (626) 415-1488
E: info@exozymes.com

 

© eXoZymes Inc. [Nasdaq:EXOZ] unshackling enzymes since 2019 (formerly known as Invizyne Technologies)

Videos Webinars Investors SEC Filings Privacy Policy Terms of Use